6-Chloropurine

CAS No. 87-42-3

6-Chloropurine( 6-Chloro-9H-purine )

Catalog No. M20873 CAS No. 87-42-3

6-Chloropurine is a building block in chemical synthesiswith Antitumor activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    6-Chloropurine
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Chloropurine is a building block in chemical synthesiswith Antitumor activities.
  • Description
    6-Chloropurine is a building block in chemical synthesiswith Antitumor activities.
  • In Vitro
    ——
  • In Vivo
    6-Chloropurine to S-(6-punnyl)glutathione and further metabolism of S-(6-punnyl)glutathione to 6-mercaptopunne may be involved in the mechanism of the 6-Chloropurine-induced antitumor activity. 6-chloropurine and azaserine have been shown to have synergic antitumor properties in a variety of mouse neoplasms when administered simultaneously.
  • Synonyms
    6-Chloro-9H-purine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    87-42-3
  • Formula Weight
    154.56
  • Molecular Formula
    C5H3ClN4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (194.09 mM)
  • SMILES
    Clc1ncnc2[nH]cnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hwang I Y Elfarra A A . Detection and mechanisms of formation of S-(6- purinyl)glutathione and 6-mercaptopurine in rats given 6- chloropurine[J]. Journal of Pharmacology and Experimental Therapeutics 1993 264(1):41-46.
molnova catalog
related products
  • Teneligliptin hydrob...

    Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.

  • JMJD6 inhibitor WL12

    2H-1-Benzopyran-2-one, 3-(3H-imidazo[4,5-c]pyridin-2-yl)-6-methyl- is a first-in-class JMJD6 inhibitor and was shown to be able to suppress JMJD6-dependent cancer cell proliferation including cervical and liver cancer cells.

  • RC-3095

    RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.